Local protein kinase A signaling pathologies in the endocrine system
Molecular Pharmacology · 2026-05 · 108 (5-6) · 100128
DOI: 10.1016/j.molpha.2026.100128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmacology, 2026-05. Verfasst von Kristan H Cleveland und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington. Hauptthemen laut MEDLINE: Cyclic AMP-Dependent Protein Kinases, Signal Transduction, Endocrine System, Endocrine System Diseases. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Endocrine signaling relies heavily on the second messenger cAMP to influence different functional outcomes including hormone secretion, steroidogenesis, ion channel regulation, and cell growth. Selectivity of cAMP action is often achieved through compartmentalized activation of protein kinase A (PKA). Local PKA action is organized by A-kinase anchoring proteins. These organellar enzyme scaffolds not only define where and when PKA phosphorylation occurs but also influence which substrates are accessible. A substantial literature suggests that endocrine disease can arise from lesions that promote dysfunctional PKA signaling. Recent studies suggests that common PKA mutations disrupt localization, causing the mutant catalytic subunits to escape A-kinase anchoring protein complexes. Such pathological events are evident in endocrine disorders such as Carney complex, sporadic primary pigmented nodular adrenocortical disease, and adrenal Cushing syndrome where somatic mutations in PKA subunits uncouple normal spatial control of the kinase. We postulate that future therapies should aim to restore the fidelity of local PKA signaling. SIGNIFICANCE STATEMENT: Compartmentalized cAMP signaling, organized by A-kinase anchoring protein scaffolds, is essential for ensuring precise spatial and functional control of endocrine processes. Disruption of this localization by disease-associated protein kinase A mutations uncouples signaling fidelity and drives endocrine pathologies, highlighting restoration of localized protein kinase A activity as a promising therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington.
- Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington. Electronic address: scottjdw@uw.edu.
Förderung
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Cleveland, K. H., & Scott, J. D. (2026). Local protein kinase A signaling pathologies in the endocrine system. Molecular Pharmacology, 108(5-6), 100128. https://doi.org/10.1016/j.molpha.2026.100128
Vancouver
Cleveland KH, Scott JD. Local protein kinase A signaling pathologies in the endocrine system. Molecular Pharmacology. 2026;108(5-6):100128. doi:10.1016/j.molpha.2026.100128
BibTeX
@article{Cleveland2026,
author = {Cleveland, Kristan H and Scott, John D},
title = {Local protein kinase A signaling pathologies in the endocrine system},
journal = {Molecular Pharmacology},
year = {2026},
volume = {108},
number = {5-6},
pages = {100128},
doi = {10.1016/j.molpha.2026.100128}
}
EUVIMED